Sumitomo Mitsui Trust Holdings, Inc. Adaptive Biotechnologies Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,299,684 shares of ADPT stock, worth $54.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,299,684
Previous 6,085,690
29.35%
Holding current value
$54.4 Million
Previous $45.2 Million
10.78%
% of portfolio
0.03%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding ADPT
# of Institutions
261Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$380 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$143 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$79.2 Million1.68% of portfolio
-
Nikko Asset Management Americas, Inc.4.3MShares$54.4 Million0.53% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.81B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...